ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
28 | (±¹³»)SCOPUS | °´Ç÷ ȯÀÚ¿¡¼ ±â°üÁö°æ¼úÀ̳ª ±â°üÁöµ¿¸Æ»öÀü¼ú ½ÃÇà ÀüÀÇ ´ÙÁß ÀýÆí Àü»êÈ´ÜÃþÃÔ¿µÀÇ À¯¿ë¼º |
27 | (±¹¿Ü)SCIE | Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats |
26 | (±¹¿Ü)SCI | Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype |
25 | (±¹³»)KCI | ¸¸¼ºÆó¼â¼ºÆóÁúȯ ±Þ¼º ¾ÇÈ·Î ÀÔ¿øÇÑ È¯ÀÚÀÇ ¼¼±Õ¼º ¿øÀÎ |
24 | (±¹¿Ü)SCIE | Prostatic metastasis of large cell neuroendocrine carcinoma of the lung |
23 | (±¹¿Ü)SCI | Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis |
22 | (±¹¿Ü)SCIE | Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD |
21 | (±¹¿Ü)SCI | CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease |
20 | (±¹¿Ü)SCI | Lung Function Response to 12-week Treatment with Combined Inhalation of Long-acting ¥â2 Agonist and Glucocorticoid According to ADRB2 Polymorphism in Patients with Chronic Obstructive Pulmonary Disease |
19 | (±¹¿Ü)SCI | Bronchobiliary fistula treated with histoacryl embolization under bronchoscopic guidance |
Copyright ¨Ï chamc, All rights reserved.